Cholestasis affects enteral tolerance and prospective weight gain in the NICU.

Affiliation

Department of Pediatrics, Division of Gastroenterology, Hepatology & Nutrition, University of Virginia, Charlottesville, VA 22903, USA. Electronic address: [Email]

Abstract

Intestinal Failure-Associated Liver Disease is characterized by cholestasis and hepatic dysfunction due to parenteral nutrition (PN) therapy. We described key features of cholestatic infants receiving PN to assess overall outcomes in this population at our institution.

OUR Recent Articles